ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $481,000 | -41.1% | 644,553 | -23.3% | 0.00% | – |
| Q2 2023 | $816,000 | +1992.3% | 840,393 | +1779.4% | 0.00% | – |
| Q1 2023 | $39,000 | – | 44,715 | +248316.7% | 0.00% | – |
| Q4 2022 | $0 | – | 18 | +38.5% | 0.00% | – |
| Q3 2022 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 13 | -99.0% | 0.00% | – |
| Q1 2022 | $3,000 | -94.2% | 1,311 | -69.9% | 0.00% | – |
| Q4 2021 | $52,000 | +92.6% | 4,362 | +146.7% | 0.00% | – |
| Q3 2021 | $27,000 | +3.8% | 1,768 | +37.7% | 0.00% | – |
| Q2 2021 | $26,000 | +85.7% | 1,284 | +103.8% | 0.00% | – |
| Q1 2021 | $14,000 | -6.7% | 630 | +16.0% | 0.00% | – |
| Q4 2020 | $15,000 | – | 543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,808,000 | 4.30% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $899,000 | 0.45% |
| Vivo Capital, LLC | 3,547,030 | $4,292,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,547,710 | $1,873,000 | 0.28% |
| Newtyn Management, LLC | 962,088 | $1,164,000 | 0.22% |
| EcoR1 Capital, LLC | 3,948,360 | $4,778,000 | 0.16% |
| Boxer Capital, LLC | 1,526,048 | $1,847,000 | 0.12% |
| Novo Holdings A/S | 1,950,000 | $2,360,000 | 0.12% |
| HHLR ADVISORS, LTD. | 2,365,064 | $2,862,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 58,392 | $71,000 | 0.02% |